Brief: Mankind Pharma Buys Rivotril Brand From Roche For India
18/03/2026 05:51
March 18 (Reuters) - Mankind Pharma Ltd MNKI.NS: MANKIND PHARMA - BUYS RIVOTRIL BRAND FROM ROCHE FOR INDIA MANKIND PHARMA - BUYS EXCLUSIVE RIGHTS TO MANUFACTURE, MARKET AND DISTRIBUTE RIVOTRIL IN INDIA Source text: ID:nNSE4BvRfv Further company coverage: MNKI.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery